Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FLUNITRAZEPAM Cause Neuroleptic malignant syndrome? 55 Reports in FDA Database

Wake Up Pain-Free — Sleep Like Never Before

Derila Ergo Pillow: ergonomic design, cooling tech. 75% OFF today.

Shop Now — 75% Off

According to the FDA Adverse Event Reporting System (FAERS), 55 reports of Neuroleptic malignant syndrome have been filed in association with FLUNITRAZEPAM. This represents 5.8% of all adverse event reports for FLUNITRAZEPAM.

55
Reports of Neuroleptic malignant syndrome with FLUNITRAZEPAM
5.8%
of all FLUNITRAZEPAM reports
5
Deaths
42
Hospitalizations

How Dangerous Is Neuroleptic malignant syndrome From FLUNITRAZEPAM?

Of the 55 reports, 5 (9.1%) resulted in death, 42 (76.4%) required hospitalization, and 11 (20.0%) were considered life-threatening.

Is Neuroleptic malignant syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FLUNITRAZEPAM. However, 55 reports have been filed with the FAERS database.

What Other Side Effects Does FLUNITRAZEPAM Cause?

Toxicity to various agents (177) Overdose (141) Intentional overdose (96) Suicide attempt (67) Altered state of consciousness (65) Off label use (58) Drug interaction (41) Somnolence (41) Completed suicide (40) Drug ineffective (39)

What Other Drugs Cause Neuroleptic malignant syndrome?

QUETIAPINE (1,756) OLANZAPINE (1,748) RISPERIDONE (1,258) HALOPERIDOL (1,244) ARIPIPRAZOLE (1,138) CLOZAPINE (899) LITHIUM (506) LORAZEPAM (437) PALIPERIDONE (355) VALPROIC ACID (352)

Which FLUNITRAZEPAM Alternatives Have Lower Neuroleptic malignant syndrome Risk?

FLUNITRAZEPAM vs FLUOCINOLONE FLUNITRAZEPAM vs FLUOCINOLONE ACETONIDE FLUNITRAZEPAM vs FLUOCINOLONE ACETONIDE\HYDROQUINONE\TRETINOIN FLUNITRAZEPAM vs FLUOCINONIDE FLUNITRAZEPAM vs FLUORESCEIN

Related Pages

FLUNITRAZEPAM Full Profile All Neuroleptic malignant syndrome Reports All Drugs Causing Neuroleptic malignant syndrome FLUNITRAZEPAM Demographics